Manufacturers

Taj Pharma India Ltd

Salt Composition

Cyproheptadine (4mg)

Medicine Type

drugs

Introduction

In Treatment of Allergic conditions Hito-En 4mg Tablet prevents the release of substances in the body that cause inflammation and symptoms such as blocked or runny nose, sneezing, and itchy or watery eyes. It can be used to treat a great many different inflammatory and allergic conditions. It lowers your immune system’s response to these conditions so you should avoid being near people who are ill or have infections.

Benefits

Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Hito-En 4mg Tablet may be taken with or without food, but it is better to take it at a fixed time.

Description

Hito-En 4mg Tablet belongs to a group of medicines called antihistamines. It is used in the treatment of various allergic conditions. It relieves symptoms of inflammation as well as itching, swelling and rashes. It is also used to treat loss of appetite (need for food). It is an effective hunger stimulant.Hito-En 4mg Tablet can be taken with or without food and it is better to take it in a dose and duration as advised by the doctor. You may need this medicine only on days you have symptoms, or you may need to take it every day to prevent symptoms from happening. If you stop taking it earlier than advised, your symptoms may come back. This medicine is generally very safe.This medicine may cause some amount of dizziness, so do not drive or do anything that needs attention. Consult your doctor if it persists or worries you. It may cause a headache in some cases. Before taking it, you should tell your doctor if you have any problems with your liver or kidneys or with your heart. Avoid drinking alcohol as it can cause excessive drowsiness with this medicine.

How To Use

Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Hito-En 4mg Tablet may be taken with or without food, but it is better to take it at a fixed time.

Safety Advise

- Alcohol : UNSAFE

Hito-En 4mg Tablet may cause excessive drowsiness with alcohol. | - Pregnancy : CONSULT YOUR DOCTOR

Information regarding the use of Hito-En 4mg Tablet during pregnancy is not available. Please consult your doctor. | - Breast feeding : CONSULT YOUR DOCTOR

Information regarding the use of Hito-En 4mg Tablet during breastfeeding is not available. Please consult your doctor. | - Driving : UNSAFE

Hito-En 4mg Tablet may cause side effects which could affect your ability to drive.Hito-En 4mg Tablet may cause dizziness, sedation, and hypotension in elderly patients. This may affect your ability to drive. | - Kidney : CAUTION

Hito-En 4mg Tablet should be used with caution in patients with severe kidney disease. Dose adjustment of Hito-En 4mg Tablet may be needed. Please consult your doctor. | - Liver : CONSULT YOUR DOCTOR

There is limited information available on the use of Hito-En 4mg Tablet in patients with liver disease. Please consult your doctor.

If Miss

If you miss a dose of Hito-En 4mg Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.

Packaging Detail

strip of 10 tablets

Package

Strip

Qty

10

Product Form

Tablet

Prescription Required

Prescription Required

Fact Box

Chemical Class :: Dibenzocycloheptenes Derivative|Habit Forming :: No|Therapeutic Class :: VITAMINS MINERALS NUTRIENTS

Primary Use

Treatment of Allergic conditions|Appetite stimulant

Storage

Store below 30°C

Use Of

Treatment of Allergic conditions|Appetite stimulant

Common Side Effect

Dizziness | Headache | Impaired coordination | Sleepiness

Alcoholinteraction

UNSAFE

Pregnancyinteraction

CONSULT YOUR DOCTOR

Lactationinteraction

CONSULT YOUR DOCTOR

Drivinginteraction

UNSAFE

Kidneyinteraction

CAUTION

Liverinteraction

CONSULT YOUR DOCTOR

Manufacturer Address

first floor, 15-6-108 afzal gunj, hyderabad, telangana 500012

How It Works

Hito-En 4mg Tablet is an antihistamine medication. It blocks the action of certain chemical messengers that are responsible for inflammation, congestion, itching, and other allergic reactions. Due to constant increased energy intake and stimulation of growth hormone secretion, it stimulates the appetite too.

Interaction

Hito-En 4mg Tablet & Afrelect 0.5mg Tablet :

Use of Cyproheptadine should be avoided with Rasagiline at the same time | Hito-En 4mg Tablet & Afrelect 1mg Tablet :

Use of Cyproheptadine should be avoided with Rasagiline at the same time | Hito-En 4mg Tablet & Rasalect 1 Tablet :

Use of Cyproheptadine should be avoided with Rasagiline at the same time | Hito-En 4mg Tablet & Rasalect 0.5 Tablet :

Use of Cyproheptadine should be avoided with Rasagiline at the same time | Hito-En 4mg Tablet & Relgin 0.5 Tablet :

Use of Cyproheptadine should be avoided with Rasagiline at the same time | Hito-En 4mg Tablet & Rasipar 0.5mg Tablet :

Use of Cyproheptadine should be avoided with Rasagiline at the same time | Hito-En 4mg Tablet & Rasipar 1mg Tablet :

Use of Cyproheptadine should be avoided with Rasagiline at the same time | Hito-En 4mg Tablet & Relgin 1 Tablet :

Use of Cyproheptadine should be avoided with Rasagiline at the same time | Hito-En 4mg Tablet & Rasagin 0.5mg Tablet :

Use of Cyproheptadine should be avoided with Rasagiline at the same time | Hito-En 4mg Tablet & Rasagin 1mg Tablet :

Use of Cyproheptadine should be avoided with Rasagiline at the same time

Marketer Details

Taj Pharma India Ltd | first floor, 15-6-108 afzal gunj, hyderabad, telangana 500012

Reference

Katzung BG. Histamines, Serotonin, & the ErgotAlkaloids. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 285. | Sanders-Bush E, Hazelwood L. 5-Hydroxytryptamine (Serotonin) and Dopamine. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. p. 351. | Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 342-43. | Medscape. Cyproheptadine. [Accessed 01 Apr. 2019] (online) Available from: https://reference.medscape.com/drug/cyproheptadine-343389 | Cyproheptadine. Hinjwadi, Pune: Emcure Pharmaceuticals Ltd.; 2017 [Accessed 1 Apr. 2019] (online) Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/087056s045lbl.pdf | Central Drugs Standard Control Organisation (CDSCO). [Accessed 01 Apr. 2019] (online) Available from: https://cdscoonline.gov.in/CDSCO/Drugs | Cyproheptadine HCI [Drug Label]. Pune, India: Emcure Pharmaceuticals Ltd.; 2009. [Accessed 25 Jul. 2024] (online) Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/087056s045lbl.pdf